Latest AI and machine learning research in skin cancer for healthcare professionals.
MOTIVATION: Tumor mutational burden (TMB) is an indicator of the efficacy and prognosis of immune ch...
Melanocytic lesions occur on the surface of the skin, in which the malignant type is melanoma with a...
Immunotherapy offers the potential for durable clinical benefit but calls into question the associat...
The recent, rapid advances in immuno-oncology have revolutionized cancer treatment and spurred furth...
Skin cancers occur commonly worldwide. The prognosis and disease burden are highly dependent on the ...
Cancer therapeutics cause various treatment-related changes that may impact patient follow-up and di...
The ability to identify antigenic determinants of pathogens, or epitopes, is fundamental to guide ra...
MicroRNAs constitute small non-coding RNAs that play a pivotal role in regulating the translation an...
Advancements in dermoscopy techniques have elucidated identifiable characteristics of melanoma which...
The objective of this study was to compute threshold values for the diameter of superficial spreadin...
Skin cancer remains the most commonly diagnosed cancer in the USA with more than 1 million new cases...
BACKGROUND: To assess the additive value of dual-energy CT (DECT) over single-energy CT (SECT) to ra...
Melanoma is considered as one of the world's deadly cancers. This type of skin cancer will spread to...
A basket trial in oncology encompasses multiple "baskets" that simultaneously assess one treatment i...
Glioblastoma (GBM) is the most malignant and lethal intracranial tumor, with extremely limited treat...
General practitioners (GPs) are playing a key role in skin cancer screening. Non-melanoma skin cance...
The accurate quantification of tumor-infiltrating immune cells turns crucial to uncover their role i...
Uveal melanoma (UVM) is the most common primary intraocular human malignancy with a high mortality r...
BACKGROUND: Currently, only a fraction of patients with non-small cell lung cancer (NSCLC) treated w...
In recent clinical practice the molecular diagnostics have been significantly empowered and upgraded...
A reported 96,480 people were diagnosed with melanoma in the United States in 2019, leading to 7230 ...